دورية أكاديمية

LEFLUNOMIDE IN EARLY RHEUMATOID ARTHRITIS: INCLUSION IN THE TREATMENT STRATEGY AND PROSPECTS

التفاصيل البيبلوغرافية
العنوان: LEFLUNOMIDE IN EARLY RHEUMATOID ARTHRITIS: INCLUSION IN THE TREATMENT STRATEGY AND PROSPECTS
المؤلفون: D. E. Karateev, E. V. Orlova
المصدر: Медицинский совет, Vol 0, Iss 1S, Pp 90-96 (2017)
بيانات النشر: Remedium Group LLC, 2017.
سنة النشر: 2017
المجموعة: LCC:Medicine
مصطلحات موضوعية: early rheumatoid arthritis, leflunomide, methotrexate, treatment strategy, Medicine
الوصف: According to the literature, Leflunomide is comparable in efficacy and safety with methotrexate, including patients with early rheumatoid arthritis (RA). The drug continues to play an important role in the treatment of patients with early RA and may be considered as a main synthetic base anti-inflammatory drug which should be administered in case of impossibility of treatment by effective doses of methotrexate. The combination of Methotrexate and Leflunomide, reducing the need for biological therapy, may be an effective way to overcome tolerance to Methotrexate. The role of this combination treatment strategies for early RA may be underestimated, it is expedient to conduct further research in this direction.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: Russian
تدمد: 2079-701X
2658-5790
Relation: https://www.med-sovet.pro/jour/article/view/1667; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790
DOI: 10.21518/2079-701X-2017-0-90-96
URL الوصول: https://doaj.org/article/7cf3aec2c7c64a539d9882bd52f3aaf6
رقم الأكسشن: edsdoj.7cf3aec2c7c64a539d9882bd52f3aaf6
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:2079701X
26585790
DOI:10.21518/2079-701X-2017-0-90-96